Post-approval studies (Phase 4)Ended earlyNCT03010423
What this trial is testing
Efficacy Study of Oral Nicorandil on Improving Microvascular Function in Female Non-obstructive Coronary Artery Disease (CAD) Participants
Who this might be right for
Non-obstructive Coronary Artery Disease
Merck KGaA, Darmstadt, Germany 8